Insights
article
Accelerating Therapies With Curia From Conception to Manufacturing
Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigat...
webinar
Ensuring Patient Safety: Decoding FDA’s Rating System for CDMOs
This program aims to encourage drug manufacturers to implement quality management practices that go beyond current good manufacturing practice (CGMP) requirements.
webinar
Scale-up and Production of Key lipids used in mRNA Delivery Systems
This webinar will explore the specific requirements for industrializing processes in the production of ionizable lipids and PEG lipids, elucidating concepts to address typical challenges.
webinar
From Conception to Manufacturing. Accelerating Therapies with Curia
In this podcast, we will explore the advantages of partnering with a Contract Development and Manufacturing Organization (CDMO) to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness...
webinar
Customized mRNA Processing for Improved Therapy Development and Manufacturing
In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.
article
Trends and Challenges in the Pharmaceutical Industry
Significant changes have taken place in the life sciences industry over the past few years. Since the Covid-19 pandemic, the U.S. government has urged biotech and pharmaceutical companies to increase domestic production in order to secure the drug su...
webinar
The Shift Toward US Pharmaceutical Manufacturing
The COVID-19 pandemic brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. In this webinar we will discuss drivers to consider i...
webinar
RNA Vaccines: Quality Concepts in GMP IVT mRNA Development, Manufacturing & Analytics
This webinar will provide a general overview of mRNA therapeutics design and production and discuss the importance of robust quality systems in the context of GMP production of mRNA therapeutics.
webinar
Ensuring Patient Safety: Decoding FDA’s Rating System for CDMOs
To optimize manufacturing process performance and product quality, enhance supply chain reliability, and foster proactive continual improvement, the FDA’s Center for Drug Evaluation and Research (CDER) has established a program to promote quality m...
article
CMC Best Practices: Expediting Orphan Drug Development to Combat Rare Disease
February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.
fact sheet
Comprehensive mRNA Solutions
Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.
infographic
Curia's Recently Filed DMFs
We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.